期刊文献+

小鼠nNOS(AA1-133)基因慢病毒载体的构建及功能初步检测 被引量:1

Construction and detection of lentiviral vector carrying mouse nNOS(AA1-133)
下载PDF
导出
摘要 目的:构建含nNOS(AA1-133)基因的慢病毒载体,检测其表达和功能。方法:采用RT-PCR扩增小鼠nNOS(AA1-133)基因,构建真核表达载体pIRES2-EGFP/nNOS(AA1-133)。鉴定正确后将目的基因克隆入慢病毒载体pGC-FU,得重组载体pGC-FU/nNOS(AA1-133),采用Lipofectamine 2000将其转染293T细胞,包装慢病毒颗粒后感染原代神经元,检测目的片段的表达和功能。结果:成功扩增小鼠nNOS(AA1-133)基因片段,测序证明重组慢病毒载体pGC-FU/nNOS(AA1-133)构建成功,包装后的慢病毒颗粒可以感染神经元,目的片段可在神经元中表达并与PSD95结合。结论:慢病毒载体pGC-FU/nNOS(AA1-133)构建成功,目的片段在原代神经元中可表达并发挥功能。 Objective:To construct the lentiviral vector carrying nNOS(AA1-133)and detect its expression and function.Methods:Mouse nNOS(AA1-133)was amplified by RT-PCR and then eukaryotic expression vector of pIRES2-EGFP / nNOS(AA1-133)was constructed.After DNA sequence analysis,nNOS(AA1-133)was cloned into lentiviral vector pGC-FU to construct recombinant vector pGC-FU / nNOS(AA1-133).pGC-FU / nNOS(AA1-133)was transfected into 293T cells by Lipofectamine 2000 mediation to package lentiviral particles.The particles were transfected into primary neurons,and the expression and function of nNOS(AA1-133)were detected.Results:The coding sequence of mouse nNOS(AA1-133)was successfully amplified and the analysis of DNA sequence approved that the recombinant lentiviral vector contained nNOS(AA1-133).nNOS(AA1-133)expressed and combined with PSD95 in the infected neurons.Conclusion:The lentiviral vector of pGC-FU/nNOS(AA1-133)was constructed successfully and the infected neurons could express nNOS(AA1-133).
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2010年第7期895-899,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助(30971021)
关键词 NNOS 构建 真核表达载体 慢病毒载体 nNOS construct eukaryotic expression vector lentiviral vector
  • 相关文献

参考文献16

  • 1Lipton SA. Pathologically activated therapeutics for neuroprotection [ J ]. Nat Rev Neurosci, 2007,8 (10) : 803 -808.
  • 2Cao J,Viholainen JI,Dart C,et al. The PSD95-nNOS interface:a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death[J]. J Cell Biol, 2005,168( 1 ) : 117-126.
  • 3Basel J, Gandor F, Harms C. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurons [J]. J Neurochem,2005,92(6): 1386-1398.
  • 4萨姆布鲁克·拉塞尔.分子克隆实验指南[M].黄培堂,译.3版.北京:科学出版社,2002.
  • 5Zellmer S, Gaunitz F, Salvetter J, et al. Long-term expression of foreign genes in normal human epidermal keratinocytes after transfeetion with lipid /DNA complexes [J]. Histochem Cell Biol,2001,115( 1 ):41-47.
  • 6Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade:memantine and beyond [J]. Nat Rev Drug Discov, 2006,5 (2) : 160-170.
  • 7Kind PC,Neumann PE. Plasticity : downstream of glutamate[J]. Trends Neurosci ,2001,24(10) :553-555.
  • 8Wang CX, Shuaib A. NMDA/NR2B selective antagonists in the treatment of ischemic brain injury [J]. Curr Drug Targets CNS Neurol Disord, 2005,4(2) : 143-151.
  • 9Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology:excitatory times ahead [J]. Lancet Neurol, 2008,7(8) ,742-755.
  • 10Chaudhury A,He XD,Goyal RK. Role of PSD95 in membrane association and catalytic activity of nNOSα in nitrergic varicosities in mice gut[J]. Am J Physiol Gastrointest Liver Physiol, 2009,297 (4) : 806-813.

共引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部